Evidence map›Paper›PMID 25886253›Full record

ArticlePloS one2015

The 15kDa selenoprotein and thioredoxin reductase 1 promote colon cancer by different pathways.

Petra A Tsuji, Bradley A Carlson, Min-Hyuk Yoo, Salvador Naranjo-Suarez, Xue-Ming Xu, Yiwen He, Esther Asaki, Harold E Seifried, William C Reinhold, Cindy D Davis and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Environmental Selenium and Human Health: an Update.Current environmental health reports · 2018
    Review
  16. Review
  17. Selenoproteins in colon cancer.Free radical biology & medicine · 2018
    Review
  18. Review
  19. Review
  20. Selenoproteins and Metastasis.Advances in cancer research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Petra A TsujiDepartment of Biological Sciences, Towson University, Towson, Maryland, United States of America.
Bradley A CarlsonMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Institutes of Health, Bethesda, Maryland, United States of America.
Min-Hyuk YooMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Institutes of Health, Bethesda, Maryland, United States of America.
Salvador Naranjo-SuarezMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Institutes of Health, Bethesda, Maryland, United States of America.
Xue-Ming XuMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Institutes of Health, Bethesda, Maryland, United States of America.
Yiwen HeCenter for Information Technology, National Institutes of Health, Bethesda, Maryland, United States of America.
Esther AsakiCenter for Information Technology, National Institutes of Health, Bethesda, Maryland, United States of America.
Harold E SeifriedNutritional Science Research Group, National Institutes of Health, Rockville, Maryland, United States of America.
William C ReinholdGenomics & Informatics Group, Laboratory of Molecular Pharmacology, National Institutes of Health, Bethesda, Maryland, United States of America.
Cindy D DavisOffice of Dietary Supplements, National Institutes of Health, Rockville, Maryland, United States of America.
Vadim N GladyshevBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Dolph L HatfieldMolecular Biology of Selenium Section, Mouse Cancer Genetics Program, National Institutes of Health, Bethesda, Maryland, United States of America.
National Institutes of Health · USCancer Genetics (United States) · USHarvard University · USOffice of Dietary Supplements · USTowson University · US

Funding

Selenoproteins as Targets for Cancer PreventionR01CA080946 · NCI · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2001 to 2018
$4.5M
Functions of thioredoxin reductases and their targetsR37GM065204 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2011 to 2020
$4.0M
Functions of Mammalian Thioredoxin ReductasesR01GM065204 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GLADYSHEV, VADIM N. · 2002 to 2009
$2.2M
Selenium in Health and its incorporation into Protein as SelenocysteineZIABC011620 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HATFIELD, DOLPH · 2015 to 2016
$587k
Intramural NIH HHSNCI NIH HHS CA080946NCI NIH HHS R01 CA080946NIGMS NIH HHS GM065204NIGMS NIH HHS R01 GM065204NIGMS NIH HHS R37 GM065204
6 · The paper itself

Abstract

Selenoproteins mediate much of the cancer-preventive properties of the essential nutrient selenium, but some of these proteins have been shown to also have cancer-promoting effects. We examined the contributions of the 15kDa selenoprotein (Sep15) and thioredoxin reductase 1 (TR1) to cancer development. Targeted down-regulation of either gene inhibited anchorage-dependent and anchorage-independent growth and formation of experimental metastases of mouse colon carcinoma CT26 cells. Surprisingly, combined deficiency of Sep15 and TR1 reversed the anti-cancer effects observed with down-regulation of each single gene. We found that inflammation-related genes regulated by Stat-1, especially interferon-γ-regulated guanylate-binding proteins, were highly elevated in Sep15-deficient, but not in TR1-deficient cells. Interestingly, components of the Wnt/β-catenin signaling pathway were up-regulated in cells lacking both TR1 and Sep15. These results suggest that Sep15 and TR1 participate in interfering regulatory pathways in colon cancer cells. Considering the variable expression levels of Sep15 and TR1 found within the human population, our results provide insights into new roles of selenoproteins in cancer.

Indexed as

AnimalsCell Line, TumorCell ProliferationColonic NeoplasmsGene Expression ProfilingMiceMice, Inbred BALB CNeoplasm MetastasisSelenoproteinsThioredoxin Reductase 1Selenof protein, mouseSelenoproteinsThioredoxin Reductase 1

Identifiers

PMID25886253
PMCPMC4401539
OpenAlexW2049421472

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.